Amicus Therapeutics (FOLD) Tops Q4 EPS by 7c, Comments on FY09
Tweet Send to a Friend
Amicus Therapeutics, Inc. (Nasdaq: FOLD) reports Q4 loss of $0.55, 7 cents better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
